Skip to main content
Caplight Logo









Apratima Biosolutions

Apratima Biosolutions

Private
BangaloreHealthcare & Life Scienceshttps://www.apratima.com/

Last Round

Seed

May 13, 2025

Company Overview

Apratima Biosolutions is a biotechnology company that develops AI-assisted protein and enzyme design systems to degrade plastic waste into chemical building blocks for circular economy applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

biochemical reagentsdiagnostic raw materialscustom synthesiscontract manufacturingenzyme engineeringprotein engineeringbiotech supply chainmolecular dynamicsdiagnostic assay componentslab chemicalsCDMOprotein designbiotech R&Din silico analysissynthetic biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Apratima Biosolutions Comparables

Compare Apratima Biosolutions with similar companies based on industry and business-model similarity.

Apratima Biosolutions comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Birch Biosciences
34%
Protein Evolution, Inc.
32%

Apratima Biosolutions Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 13, 2025
GrantMar 1, 2025

Apratima Biosolutions Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Monthly visitors grew 102% MoM, reaching 208.

  • Jan 19, 2026

    Monthly visitors increased 2308% MoM, reaching 8.4K.

Apratima Biosolutions Filings

Explore SEC and related filing metadata, where available.

Apratima Biosolutions filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Apratima Biosolutions's valuation, stock price, and market status.

Is Apratima Biosolutions a public or private company?

Apratima Biosolutions is a private company.

What is the current stock price of Apratima Biosolutions?

Apratima Biosolutions is a private company with no public stock price. No recent secondary market data is available.

How much is Apratima Biosolutions worth (valuation)?

Valuation information for Apratima Biosolutions is not publicly available.

Can I buy Apratima Biosolutions stock?

Apratima Biosolutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Apratima Biosolutions's last funding round?

Apratima Biosolutions's most recent funding round was Seed on May 13, 2025.

Who are the main investors in Apratima Biosolutions?

Key investors in Apratima Biosolutions include N. S. Raghavan Centre for Entrepreneurial Learning, Pernod Ricard India Foundation, Rainmatter Capital Fund, Foundation for Science, Innovation and Development.

Will Apratima Biosolutions IPO soon?

No public IPO plans have been announced for Apratima Biosolutions.

How can I track Apratima Biosolutions secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Apratima Biosolutions's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBangalore
Employee Range6
Year Founded2022
Last FundingMay 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?